FindTrial
Sign In

Therapeutic evaluation and follow-up study of myasthenia gravis treated by integrated traditional chinese and western medicine based on the real world study

Therapeutic evaluation and follow-up study of myasthenia gravis treated by integrated traditional chinese and western medicine based on the real world study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024369
Enrollment
Unknown
Registered
2019-07-07
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myasthenia gravis

Interventions

Case Series:Traditional Chinese and Western Medicine Treatment

Sponsors

The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: From August 2019 to December 2039, patients with myasthenia gravis were diagnosed in the outpatient and inpatient departments of the center.

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

MeasureTime frame
MGC grade;PRO scale;ADL grade;Glucocorticoid dosage;Serum levels of inflammatory factors;the occurrence of myasthenic crisis during hospitalization and within 10 years;recurrence rate;mortality;—

Countries

China

Contacts

Public ContactQilong Jiang

Department of Spleen-Stomach, the First Affiliated Hospital of Guangzhou University of Chinese Medicine

jqllpzx@126.com+86 15989082142

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026